Preclinical Development of PQR514, a Highly Potent PI3K Inhibitor Bearing a Difluoromethyl–Pyrimidine Moiety | ACS Medicinal Chemistry Letters
![Life Beyond Kinases: Structure-Based Discovery of Sorafenib as Nanomolar Antagonist of 5-HT Receptors | Journal of Medicinal Chemistry Life Beyond Kinases: Structure-Based Discovery of Sorafenib as Nanomolar Antagonist of 5-HT Receptors | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/jm300338m/asset/images/large/jm-2012-00338m_0001.jpeg)
Life Beyond Kinases: Structure-Based Discovery of Sorafenib as Nanomolar Antagonist of 5-HT Receptors | Journal of Medicinal Chemistry
Life Beyond Kinases: Structure-Based Discovery of Sorafenib as Nanomolar Antagonist of 5-HT Receptors | Journal of Medicinal Chemistry
![Life Beyond Kinases: Structure-Based Discovery of Sorafenib as Nanomolar Antagonist of 5-HT Receptors | Journal of Medicinal Chemistry Life Beyond Kinases: Structure-Based Discovery of Sorafenib as Nanomolar Antagonist of 5-HT Receptors | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/jm300338m/asset/images/medium/jm-2012-00338m_0007.gif)